UBS
-
The Swiss medical company said it opted for a direct listing for tax purposes -
The firm priced its share at HK$158, with the top 15 investors taking around 70% of the offer
-
Hong Kong's largest IPO of the year is anchored by nine cornerstone investors
-
Decent sizes available in Swiss francs for high quality offshore names
-
Chinese duty-free retail chain prepares for largest listing of the year in Hong Kong
-
Although the spread between Pfandbriefe and cantonal bank paper has widened, both still remain attractive
-
Tight strategies amid high volatility appear to be working, with the exception of Credit Suisse which reported losses
-
UBS joins UK lender for post-earnings dollar market visit
-
A cloud computing giant, a fruit distributor, and trio of medical companies seek IPOs
-
Chinese property developer's shares sunk after fleeting rally
-
Distiller lists in Singapore by introduction to expand liquor empire
-
Chinese manufacturers are contemplating listing in Switzerland as the Shanghai-London Stock Connect scheme has been extended
